Skip to main content
Clinical Trials/NCT00758173
NCT00758173
Unknown
Not Applicable

A Population Based Study of Genetic Predisposition and Gene-Environment Interactions in Prostate Cancer in East Anglia, Trent and West Midlands

Cancer Research UK1 site in 1 country2,000 target enrollmentFebruary 2008
ConditionsProstate Cancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Prostate Cancer
Sponsor
Cancer Research UK
Enrollment
2000
Locations
1
Primary Endpoint
Evaluation interactions between polymorphisms in predisposition genes and potential lifestyle risk factors
Last Updated
12 years ago

Overview

Brief Summary

RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.

PURPOSE: This study is looking at genetic susceptibility and the interactions between genes and the environment in patients with prostate cancer.

Detailed Description

OBJECTIVES: * To obtain epidemiological information and biological material on a population-based series of prostate cancer cases. * To identify novel cancer susceptibility genes by comparison of genotype frequencies in cases with the corresponding frequencies in large control series. * To estimate the age and sex-specific risks associated with variants in predisposition genes. * To evaluate interactions between polymorphisms in predisposition genes and potential lifestyle risk factors. OUTLINE: This is a multicenter study. Patients complete a detailed epidemiological questionnaire, including information on education, occupation, smoking habits, alcohol consumption, height, weight, family history of cancer, and past medical history. Blood samples are collected from patients. DNA is extracted from these blood samples and from samples collected from cancer-free control participants in MREC-SEARCH-CONTROL as well as from additional controls through the European Prospective Investigation of Cancer (EPIC) study (a population based study of diet and health based in Norfolk, East Anglia). DNA samples are analyzed for polymorphisms of low penetrance cancer susceptibility genes. In addition to the prostate cancer patients recruited for this study, patients with breast, ovarian, endometrial, colorectal, bladder, kidney, pancreatic, brain and esophageal cancer, malignant melanoma, and lymphoma cancer are recruited in the following related clinical trials: MREC-SEARCH-BREAST, MREC-SEARCH-OVARIAN, MREC-SEARCH-ENDOMETRIAL, MREC-SEARCH-COLORECTAL, and MREC-SEARCH-CANCER.

Registry
clinicaltrials.gov
Start Date
February 2008
End Date
TBD
Last Updated
12 years ago
Study Type
Observational
Sex
Male

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Evaluation interactions between polymorphisms in predisposition genes and potential lifestyle risk factors

Acquisition of epidemiological information and biological material

Identification of novel cancer susceptibility genes

Estimation of the age and sex-specific risks associated with variants in predisposition genes

Study Sites (1)

Loading locations...

Similar Trials